JCI
Johnson Controls International plc
JCI's fundamentals are strong: its operating margin rose 5 points to 14% and free cash flow grew 75%. At 31x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth.
JCI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Stable |
JCI's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
JCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $95.28 | -33% |
| Forward | 22x | $143 | — |
| Fair | 30x | $139 | -2.7% |
| Current | 31x | $143 | — |
| Expensive | 36x | $169 | +18% |
Historical ranges are pointers, not guarantees.
JCI's PE is in its fair range at 31x. If earnings grow as analysts expect, today's price would be 22x next year's earnings, in its cheap range.
JCI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for JCI, with profitability improving.
JCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.34 | +36% |
| Q3 2026 | $4.67 | -7.2% |
| Q2 2026 | $5.68 | +70% |
| Q1 2026 | $5.53 | +48% |
| Q4 2025 | $5.25 | +102% |
| Q3 2025 | $5.03 | +100% |
| Q2 2025 | $3.35 | +40% |
| Q1 2025 | $3.73 | +51% |
| Q4 2024 | $2.60 | -15% |
JCI's earnings per share have fallen from their peak: $4.67 over the past year, against $6.32 in late 2019.
JCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.1B | +10% |
| Q2 2026 | $6.6B | +9.3% |
| Q1 2026 | $6.1B | +8.2% |
| Q4 2025 | $5.8B | +6.8% |
| Q3 2025 | $6.4B | +120% |
| Q2 2025 | $6.1B | -16% |
| Q1 2025 | $5.7B | -15% |
| Q4 2024 | $5.4B | -11% |
JCI's revenue has grown year over year for five quarters in a row: $7.1B last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +9.4 points |
| Q2 2026 | 15% | +3.3 points |
| Q1 2026 | 12% | +3.2 points |
| Q4 2025 | 12% | +4.7 points |
| Q3 2025 | 5.5% | -1.4 points |
| Q2 2025 | 12% | -6 points |
| Q1 2025 | 8.8% | +14 points |
| Q4 2024 | 7.5% | +0.9 points |
JCI's operating margin was 15% last quarter, up 9.4 points from the same quarter a year ago, near the top of its range since 2019.
JCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +29% |
| Q2 2026 | $1.5B | +117% |
| Q1 2026 | $604M | +32% |
| Q4 2025 | $531M | +299% |
| Q3 2025 | $838M | +1.5% |
| Q2 2025 | $693M | -25% |
| Q1 2025 | $456M | +$792M |
| Q4 2024 | $133M | +$471M |
JCI generated $3.7B in free cash flow over the past year, up 75% from the year before.
JCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -2M shares |
| 1 year | -6.6% | -43.1M shares |
| 3 years | -11% | -76.4M shares |
| 5 years | -15% | -110M shares |
| Available history | -21% | -163M shares |
JCI has 611M diluted shares, down 6.6% from a year ago, with $1.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $655M |
| Q2 2026 | $264M |
| Q1 2026 | $215M |
| Q4 2025 | — |
| Q3 2025 | $5B |
| Q2 2025 | $310M |
| Q1 2025 | $330M |
| Q4 2024 | $330M |
JCI spent $1.1B buying back its own shares over the past year, down 81% from the year before.
JCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 2.5x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 3.0x | Moderate |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 3.8x | Elevated |
| Q1 2025 | 2.9x | Moderate |
| Q4 2024 | 3.8x | Elevated |
JCI's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
JCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 35.5 | Neutral |
JCI's weekly RSI is 50 (neutral) and its Stochastic is 35 (neutral).
JCI PE vs Industrials Sector
| Metric | JCI | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 24x | 27% above |
| PE % | 56 | 58 | 2 pts below |
JCI is trading at 31x earnings, a 27% premium to the Industrials sector's median of 24x.
JCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $147.5 | 3.3% below |
| 20 week MA | $145.8 | 2.2% below |
| 50 week MA | $137.7 | 3.5% above |
| 100 week MA | $117.3 | 22% above |
| 200 week MA | $90.8 | 57% above |
JCI has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 57% above its 200-week average.
JCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.1 | $45.9 | +12% |
| 2021 | $45.9 | $78.1 | +70% |
| 2022 | $78.1 | $64.1 | -18% |
| 2023 | $64.1 | $57.6 | -10% |
| 2024 | $57.6 | $79.8 | +38% |
| 2025 | $79.8 | $122.1 | +53% |
| 2026 YTD | $122.1 | $142.6 | +17% |
JCI has finished higher in four of the last six years, two of them by more than 50%. It's up 17% so far in 2026.